| NDC Code | 69680-183-30 |
|---|
| Package Description | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69680-183-30) |
|---|
| Product NDC | 69680-183 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Memantine Hydrochloride And Donepezil Hydrochloride |
|---|
| Non-Proprietary Name | Memantine Hydrochloride And Donepezil Hydrochloride |
|---|
| Dosage Form | CAPSULE, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20250716 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA216901 |
|---|
| Manufacturer | Vitruvias Therapeutics, Inc. |
|---|
| Substance Name | DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE |
|---|
| Strength | 10; 14 |
|---|
| Strength Unit | mg/1; mg/1 |
|---|
| Pharmacy Classes | Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA], N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA] |
|---|